» Articles » PMID: 3358883

Concentration-time Profiles of Ethanol and Acetaldehyde in Human Volunteers Treated with the Alcohol-sensitizing Drug, Calcium Carbimide

Overview
Specialty Pharmacology
Date 1988 Feb 1
PMID 3358883
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

1. The disposition kinetics of ethanol and its toxic metabolite acetaldehyde were investigated in 10 healthy male volunteers who ingested 0.25 g kg-1 ethanol after an overnight fast. This dose of ethanol was given 2 h after they swallowed a tablet of either calcium carbimide CC (50 mg), a potent inhibitor of low Km aldehyde dehydrogenase (ALDH), or placebo according to a single-blind crossover design. 2. The pulmonary blood concentrations of ethanol and acetaldehyde were estimated indirectly by means of a gas chromatographic method modified for analysis of end-expired breath. This non-invasive sampling technique allowed replicate determinations at 15 min intervals. 3. The distribution volume of ethanol (V) was 0.64 +/- 0.023 1 kg-1 after CC and 0.68 +/- 0.026 l kg-1 after placebo treatment (P greater than 0.05). The zero order slope of the blood-ethanol decay profile (ko) decreased by about 5% when low Km ALDH was inhibited. The elimination of ethanol from the body (V X ko) was 1.9 +/- 0.051 mmol kg-1 h-1 after CC compared with 2.11 +/- 0.056 mmol kg-1 h-1 in placebo control experiments (P less than 0.001). The area under the ethanol concentration time curve (0----180 min) increased after CC treatment implying a change in clearance. 4. The disposition of acetaldehyde was markedly different in subjects pretreated with CC. The peak blood-concentrations, estimated by analysis of breath, ranged from 40-242 mumol l-1 compared with 1.7-6.5 mumol l-1 after placebo.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

A physiologically-based digital twin for alcohol consumption-predicting real-life drinking responses and long-term plasma PEth.

Podeus H, Simonsson C, Nasr P, Ekstedt M, Kechagias S, Lundberg P NPJ Digit Med. 2024; 7(1):112.

PMID: 38702474 PMC: 11068902. DOI: 10.1038/s41746-024-01089-6.


Integration of a physiologically-based pharmacokinetic model with a whole-body, organ-resolved genome-scale model for characterization of ethanol and acetaldehyde metabolism.

Zhu L, Pei W, Thiele I, Mahadevan R PLoS Comput Biol. 2021; 17(8):e1009110.

PMID: 34351898 PMC: 8370625. DOI: 10.1371/journal.pcbi.1009110.


Effects of ethanol and ethanol metabolites on intrinsic function of mesenteric resistance arteries.

Eby J, Majetschak M PLoS One. 2019; 14(3):e0214336.

PMID: 30893362 PMC: 6426218. DOI: 10.1371/journal.pone.0214336.


Disulfiram-like Reaction Involving Ceftriaxone in a Pediatric Patient.

Small S, Bacher R, Jost S J Pediatr Pharmacol Ther. 2018; 23(2):168-171.

PMID: 29720921 PMC: 5916447. DOI: 10.5863/1551-6776-23.2.168.

References
1.
Brien J, Peachey J, Rogers B, Loomis C . A study of the calcium carbimide-ethanol interaction in man. Eur J Clin Pharmacol. 1978; 14(2):133-41. DOI: 10.1007/BF00607445. View

2.
Jones A . Excretion of low-molecular weight volatile substances in human breath: focus on endogenous ethanol. J Anal Toxicol. 1985; 9(6):246-50. DOI: 10.1093/jat/9.6.246. View

3.
MIZOI Y, Ijiri I, Tatsuno Y, Kijima T, Fujiwara S, Adachi J . Relationship between facial flushing and blood acetaldehyde levels after alcohol intake. Pharmacol Biochem Behav. 1979; 10(2):303-11. DOI: 10.1016/0091-3057(79)90105-9. View

4.
Pikkarainen P, BARAONA E, Jauhonen P, Seitz H, Lieber C . Contribution of oropharynx microflora and of lung microsomes to acetaldehyde in expired air after alcohol ingestion. J Lab Clin Med. 1981; 97(5):631-6. View

5.
Sellers E, Naranjo C, Peachey J . Drug therapy: Drugs to decrease alcohol consumption. N Engl J Med. 1981; 305(21):1255-62. DOI: 10.1056/NEJM198111193052105. View